Anti-cancer cell therapies and the end of the CRISPR-Cas9 controversy.
Oncology is the most advanced area in genomics right now. The field is setting the standard for other indications to follow and improve upon.
A new UK based project, seeks to improve understanding of blood cancer genomics for improved treatment.
New epigenetic study offers potential for further stratification in triple negative breast cancer.
NIH breakthrough in gene therapy for methylmalonic acidemia.
The long battle over BRCA1 and BRCA2 patent infringement finally comes to an end.
Whole-exome sequencing reveals the mutational spectrum of testicular germ cell tumours.
New study publishes important results to improve future treatment of gastric cancer.
Roche are planning on spending $1 billion to take majority control of Foundation Medicine.
Poll results and analysis. Biggest potential win in cancer.
Blackberry and NantHealth have announced the launch of a clinical genome browser for Blackberry’s Passport device.
University of Chicago and the National Cancer Institute are addressing one of genomics’ biggest bottlenecks.